Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

HISTORICAL FACTS: 53 | History Defined

MaxCyte (NASDAQ:MXCT) reported lower first-quarter revenue compared with the prior year, as management said discontinued SPL programs and inventory management by its largest customer weighed on core revenue, while milestone revenue from a registrational-stage program helped offset part of the declin

MarketBeat

National CineMedia Q1 Earnings Call Highlights

National CineMedia (NASDAQ:NCMI) reported first-quarter 2026 results that management said were in line with expectations, as the cinema advertising company faced typical seasonal weakness, advertising competition from the Winter Olympics and a one-week fiscal calendar shift. Chief Executive Officer

MarketBeat

Lumexa Imaging Q1 Earnings Call Highlights

Lumexa Imaging (NASDAQ:LMRI) reported first-quarter results that management said were in line with expectations, as growth in advanced imaging modalities helped offset seasonal volume pressure and weather-related disruptions. Chief Executive Officer Caitlin Zulla said the company “recovered our mom

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Kura Oncology Q1 Earnings Call Highlights

Kura Oncology (NASDAQ:KURA) reported $5.8 million in first-quarter net product revenue from KOMZIFTI, its first commercial product, and said the launch is showing early signs of physician uptake, broad payer coverage and use in combination regimens, according to management’s earnings call for the fi

MarketBeat

ACADIA Pharmaceuticals Targets $1B Brand Opportunity as Key Neuropsychiatry Data Looms

ACADIA Pharmaceuticals (NASDAQ:ACAD) executives said the company is focused on expanding its two commercial brands while preparing for several clinical data readouts in neuropsychiatric disorders, according to comments at the Bank of America Global Healthcare Conference. Chief Executive Officer Cat

MarketBeat

Izea Worldwide Q1 Earnings Call Highlights

Izea Worldwide (NASDAQ:IZEA) reported lower first-quarter 2026 revenue as the influencer marketing company said it completed a strategic shift away from small and midsize business accounts and toward larger enterprise clients. Chief Executive Officer Patrick Venetucci told investors that the compan

MarketBeat

HireQuest Q1 Earnings Call Highlights

HireQuest (NASDAQ:HQI) reported lower first-quarter revenue following the divestiture of certain MRI Network assets, while management said demand trends improved as the quarter progressed and have become more favorable early in the second quarter. Chief Executive Officer Rick Hermanns described the

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Hyperfine Q1 Earnings Call Highlights

Hyperfine (NASDAQ:HYPR) reported a sharp year-over-year increase in first-quarter revenue and reiterated its full-year 2026 outlook, as management pointed to continued adoption of its next-generation Swoop portable MRI system across hospitals, neurology offices and international markets. President

MarketBeat

Intellicheck Mobilisa Q1 Earnings Call Highlights

Intellicheck Mobilisa (NASDAQ:IDN) reported higher first-quarter revenue and profitability, with management saying growth in banking and lending helped offset weaker transaction volumes in retail, automotive and title insurance amid a challenging macroeconomic backdrop. President and CEO Bryan Lewi

MarketBeat

GrowGeneration Q1 Earnings Call Highlights

GrowGeneration (NASDAQ:GRWG) reported higher first-quarter 2026 revenue and a narrower loss, with management pointing to commercial business momentum, proprietary brand growth and contributions from its storage solutions segment as key drivers. On the company’s earnings call, Co-Founder and Chief E

MarketBeat

Fractyl Health Q1 Earnings Call Highlights

Fractyl Health (NASDAQ:GUTS) said it remains on track to report pivotal data for its Revita therapy in early fourth quarter 2026, as management highlighted clinical, regulatory and reimbursement developments during the company’s first-quarter 2026 earnings call. Chief Executive Officer Dr. Harith R

MarketBeat

Audioeye Q1 Earnings Call Highlights

Audioeye (NASDAQ:AEYE) reported first-quarter 2026 revenue growth and raised its profitability outlook, while outlining a leadership transition that will move Kelly Georgevich into the chief executive role and keep David Moradi focused on product strategy and artificial intelligence initiatives. Th

MarketBeat

Fold Q1 Earnings Call Highlights

Fold (NASDAQ:FLD) reported a difficult first quarter of fiscal 2026, with management citing a broad pullback in Bitcoin prices and related pressure on customer activity across the industry. On the company’s May 12 earnings call, Chairman and CEO Will Reeves said lower Bitcoin prices weighed on tran

MarketBeat

Affirm Maps Road to $100B GMV With Card, AI Commerce and Global Expansion

Affirm (NASDAQ:AFRM) used its 2026 Investor Forum at Nasdaq in New York to outline a broader growth strategy centered on its payments network, expanding consumer products, international markets and a new medium-term financial framework tied to reaching $100 billion in annual gross merchandise volume

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Evolv Technologies Q1 Earnings Call Highlights

Evolv Technologies (NASDAQ:EVLV) reported first-quarter revenue growth of 45% year over year and raised its full-year 2026 revenue outlook, citing continued demand across education, healthcare, sports and entertainment, and enterprise workplaces. President and CEO John Kedzierski said the company i

MarketBeat

Digimarc Q1 Earnings Call Highlights

Digimarc (NASDAQ:DMRC) reported sequential annual recurring revenue growth in the first quarter of 2026 while outlining progress and timing changes in its secure gift card, anti-counterfeiting and digital trust initiatives. Chief Executive Riley McCormack said the company made “significant progress

MarketBeat

Coincheck Group Q4 Earnings Call Highlights

Coincheck Group (NASDAQ:CNCK) reported higher total revenue for its fiscal fourth quarter and full year ended March 31, 2026, while lower marketplace trading volume and higher expenses weighed on adjusted revenue, net income and adjusted EBITDA. Chief Executive Officer Pascal St-Jean used the call

MarketBeat

Beachbody Q1 Earnings Call Highlights

Beachbody (NASDAQ:BODI) reported first-quarter 2026 results that management said extended the company’s financial turnaround, with revenue above guidance and a third consecutive quarter of profitability on both a net income and operating income basis. Executive Chairman Mark Goldston said total rev

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Black Rock Coffee Bar Q1 Earnings Call Highlights

Black Rock Coffee Bar (NASDAQ:BRCB) reported higher first-quarter revenue and adjusted EBITDA as the drive-thru coffee chain continued opening new locations and leaned on loyalty, menu innovation and marketing initiatives to drive guest engagement. Chief Executive Officer Mark Davis said the compan

MarketBeat

Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch

Axsome Therapeutics (NASDAQ:AXSM) executives said the company is preparing for a June launch of AUVELITY in Alzheimer’s disease agitation while continuing to expand its push in major depressive disorder, citing broad payer access, a larger sales force and what they described as a differentiated clin

MarketBeat

Mobile Infrastructure Q1 Earnings Call Highlights

Mobile Infrastructure (NASDAQ:BEEP) reported first-quarter 2026 results that management said reflected progress on utilization, contract growth and asset sales, while reaffirming its full-year outlook. Chief Executive Officer Stephanie Hogue said the company’s first-quarter performance showed “soli

MarketBeat

Capricor Therapeutics Q1 Earnings Call Highlights

Capricor Therapeutics (NASDAQ:CAPR) said its Duchenne muscular dystrophy therapy candidate deramiocel remains under active FDA review, while the company is preparing to commercialize the product itself amid a legal dispute with distribution partner NS Pharma and parent company Nippon Shinyaku. On t

MarketBeat

DoubleDown Interactive Q1 Earnings Call Highlights

DoubleDown Interactive (NASDAQ:DDI) reported higher first-quarter revenue and profit, with management pointing to growth from acquired businesses, a larger direct-to-consumer revenue mix in social casino and continued cash generation across the company. For the quarter ended March 31, 2026, the com

MarketBeat

Astronics Q1 Earnings Call Highlights

Astronics (NASDAQ:ATRO) raised its full-year 2026 revenue outlook after reporting a stronger first quarter marked by record bookings and backlog, higher margins and broad demand across its aerospace and test systems businesses. Chairman, President and CEO Peter Gunderman said the company viewed the

MarketBeat

Atea Pharmaceuticals Q1 Earnings Call Highlights

Atea Pharmaceuticals (NASDAQ:AVIR) said it remains on track for two key Phase 3 hepatitis C readouts in 2026 while advancing a newer hepatitis E program aimed at immunocompromised patients with no approved treatment options. During the company’s first-quarter 2026 earnings call, Chief Executive Off

1 … 52 53 54 55

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.